JGJan Gosepath

Jan Gosepath

*This is an algorithmically generated author record based on publicly available information.

Jan Gosepath has a total of 143 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Explainable Interface Design for Human–AI Collaboration in Confocal Laser Endomicroscopy for Head and Neck Cancer Surgery: Mixed Methods Study (Preprint)

    by Nina Wenda, Alina Döring, Stefanie Marx, Matti Sievert, Miguel Goncalves, Ralf Kiesslich, Robin Senge, Jan Gosepath

    BACKGROUND Confocal laser endomicroscopy (CLE) enables real-time, in vivo tissue assessment during head and neck cancer surgery, where the balance between oncological safety and functional preservation is particularly delicate. Artificial intelligence (AI) can support CLE interpretation, yet clinical adoption remains limited, a gap attributed less to model performance than to a lack of interfaces that make AI outputs interpretable and trustworthy at the point of care. OBJECTIVE This study aimed to investigate how explanatory, user-centered interfaces can enable reliable human–AI collaboration for AI-assisted CLE across the surgical workflow. METHODS Following a user-centered design approach, a user journey map informed the development of three high-fidelity prototypes addressing intraoperative, pre-/postoperative, and educational use cases. A mixed-methods evaluation with five experienced surgeons from four institutions combined think-aloud exploration, the short User Experience Questionnaire (UEQ-S), and semi-structured interviews; qualitative data were analysed inductively through thematic analysis. RESULTS Explainability, conveyed through influential morphological features, class activation maps, and example-based case comparisons, anchored AI recommendations in surgeons’ established clinical reasoning and supported verification against their own judgement. Explicit communication of model uncertainty emerged as a distinct prerequisite for calibrated trust. Clarity, simplicity, and adaptive information density were identified as central design principles, while diverging preferences pointed to a need for configurable interaction modes. All three prototypes were rated as excellent on the UEQ-S (overall means 2.53–2.68). CONCLUSIONS Trustworthy integration of AI into CLE depends primarily on explanatory interfaces aligned with clinical reasoning and on transparent communication of uncertainty, rather than on model performance alone. Configurable, workflow-adaptive designs and case-based educational applications represent promising directions for clinical translation.

  • Open Access

    Discordance Between p16-Expression and HPV-Status in Sinonasal Carcinoma: A Multicenter Retrospective Study

    by Nina Wenda, Henrike Barbara Zech, Marta Barde, Leoni Ramke, Anna Sophie Hoffmann, Till Clauditz, Sebastian Wagner, Jan Gosepath, Christian Stephan Betz

    Background/Objectives: Human papillomavirus (HPV) infection is a well-established risk factor for oropharyngeal squamous cell carcinoma (OPSCC), where p16 immunohistochemistry serves as a surrogate marker. However, the role of HPV in sinonasal squamous cell carcinoma (SNSCC) remains less defined, and the reliability of p16 as a standalone surrogate is under debate. This study aimed to assess the concordance between p16 expression and HPV-DNA status in SNSCC and characterize clinicopathologic features in HPV-associated cases. Methods: We retrospectively analyzed 111 SNSCC cases diagnosed between 2008 and 2024 at two German centers. p16 status was determined by immunohistochemistry using site-specific antibody protocols. HPV-DNA testing and genotyping were performed via PCR and reverse hybridization. Clinical and histopathological data were collected and compared between HPV-positive and -negative tumors. Results: HPV-DNA was detected in 31/111 cases (27.9%), with HPV16 and HPV33 (Site A) and HPV 16 and HPV18 (Site B) being the most frequent subtypes. Discordance between p16 and HPV-DNA status was observed in 29.7% of cases, with site-specific discordance rates of 44.6% and 14.5%. Patients with HPV-positive tumors were younger than their HPV-negative counterparts. Conclusions: Our findings underscore the limitations of p16 as a single surrogate marker for detecting HPV-associated sinonasal cancer. Future research on the role of HPV in sinonasal cancer should integrate complementary testing methods (like p16Ink4A immunohistochemistry and HPV DNA/mRNA analysis) and aim for test standardization.


  • Open Access

    Differentiating Sinonasal Tumor Entities with Fluorescein-Enhanced Confocal Laser Endomicroscopy: A Step Forward in Precision Diagnostics

    by Nina Wenda, Sebastian Wagner, Kai Fruth, Annette Fisseler-Eckhoff, Jan Gosepath

    Background/Objectives: Sinonasal malignancies are rare and highly diverse cancers that pose significant diagnostic challenges due to their variable histological features and complex anatomical locations. Accurate diagnosis is critical for guiding treatment, yet conventional methods often require multiple biopsies. This study aimed to evaluate the potential of confocal laser endomicroscopy (CLE) for real-time imaging of sinonasal tumors to characterize specific features of different entities and improve diagnostic precision. Methods: Ten patients with various sinonasal malignancies, including squamous cell carcinoma, adenocarcinoma, sinonasal undifferentiated carcinoma, olfactory neuroblastoma, sinonasal mucosal melanoma, and endonasal lymphoma, were examined using CLE during diagnostic endoscopy. CLE images were compared descriptively with histopathological cross-sections to identify unique imaging patterns for each tumor type. Results: CLE was feasible across all cases, with high-quality images obtained despite anatomical challenges in some cases. Characteristic features, such as vascular clusters in undifferentiated carcinoma, mucin-filled bubbles in adenocarcinoma, and small round cells in neuroblastoma, were identified and corresponded well with histopathological findings. CLE also helped guide biopsies by revealing areas with diagnostic relevance. Conclusions: CLE demonstrates promise as an adjunct diagnostic tool in sinonasal malignancies, offering real-time imaging that correlates with histopathological findings and aids in targeted biopsies. While this study provides preliminary insights into the utility of CLE, further research with larger cohorts and statistical validation is necessary to establish its diagnostic reliability and broader clinical application.


  • Open Access

    Confocal Laser Endomicroscopy in Resection of Sinonasal Malignant Melanoma—Preliminary Report on Real-Time Margin Assessment and Support in Surgical Decision-Making

    by Nina Wenda, Kai Fruth, Sebastian Wagner, Annette Fisseler-Eckhoff, Jan Gosepath

    Background/Objectives: Building upon the rising value of Confocal Laser Endomicroscopy (CLE) in squamous cell carcinoma of the head and neck, we present the first application of CLE during the resection of sinonasal malignant melanomas. This study aims to evaluate the potential of CLE to assist surgeons in intraoperative decision-making, with a particular focus on resection margin assessment within the constrained nasal cavity. Methods: Two cases of sinonasal malignant melanoma were included in this study. CLE was employed to examine visible tumors and their margins, both pre- and post-endoscopic resection. The findings were compared to histopathological results as well as data on squamous cell carcinoma, for which malignancy criteria had already been established in prior projects. Results: CLE provided the real-time visualization of sinonasal malignant melanomas and their margins, successfully differentiating between healthy and neoplastic tissue compared to histopathological findings. Conclusion: CLE offers the potential for real-time assessment, aiding surgeons in more precise tumor resection and potentially improving patient outcomes. This study demonstrates the feasibility of using CLE in the resection of sinonasal malignant melanoma, highlighting its ability to differentiate between healthy and neoplastic tissue intraoperatively.


  • Open Access

    The Multifaceted Role of Confocal Laser Endomicroscopy in Head and Neck Surgery: Oncologic and Functional Insights

    by Nina Wenda, Kai Fruth, Annette Fisseler-Eckhoff, Jan Gosepath

    (1) Background: Confocal laser endomicroscopy (CLE) has emerged as a transformative tool in head and neck surgery, with applications spanning oncologic insights and functional evaluations. This study delves into CLE’s potential in these domains. (2) Methods: We performed CLE in head and neck oncologic surgery, focusing on tumor margin identification and precise resection. We also employed CLE for functional assessment in allergic rhinitis, observing real-time mucosal changes during nasal provocation testing. (3) Results: In oncologic surgery, CLE enabled real-time visualization of tumor margins and cellular patterns, aiding resection decisions. In allergic rhinitis assessment, CLE captured dynamic morphological alterations upon allergen exposure, enhancing understanding of mucosal reactions. (4) Conclusions: The integration of CLE with evolving technologies such as deep learning and AI holds promise for enhanced diagnostic accuracy. This study underscores CLE’s expansive potential, highlighting its role in guiding surgical choices and illuminating inflammatory processes in the head and neck.


  • Open Access

    Technical Note: First Use of Endonasal Confocal Laser Endomicroscopy – Feasibility and Proof of Concept

    by Nina Wenda, Ralf Kiesslich, Jan Gosepath

    Introduction Probe-based confocal laser endomicroscopy (p-CLE) is a method for real-time in vivo visualization of mucosal changes on a cellular level. Due to the size of the endoscopes, it was mainly used in the gastrointestinal tract so far. First investigations on head and neck carcinoma described the oropharyngeal application. The further miniaturization of the laser probe now allows endonasal application and, thus, first experiences with the investigation of endonasal neoplasms. Objectives The aim of the present investigation is to elucidate, based on the morphological criteria validated in the oropharynx, whether these criteria be transferred in a similar way to the endonasal mucosa. Methods We conducted p-CLE (Cellvizio, Paris, France) with intravenous fluorescein staining in endoscopic sinus surgery in a patient with sinonasal inverted papilloma and a histologically confirmed squamous cell carcinoma. We compared the cellular visualization of pathological changes with those of healthy mucosa in the same specimen, and also with our former findings in the oropharynx. Results Endonasal p-CLE proved to be quite feasible in the surgical setting, and the transfer of malignancy criteria in analogy to histological examination could be optically retraced. Furthermore, additional criteria for tissue dignity assessment were obtained. Conclusion Our results suggest that endonasal application of p-CLE represents a valuable extension of the diagnostic repertoire available to date by an additional real-time analysis of the nasal mucosa. This is of particular value in surgically challenging anatomical areas such as the paranasal sinuses.Further investigation and validation will be necessary.


  • ID: 3526039 FOOD ALLERGY SENSITIVITY TEST (FAST) WITH ENDOMICROSCOPY OF THE DUODENUM ENABLES TAILORED EXCLUSION DIET IN PATIENTS WITH IRRITABLE BOWEL SYNDROME

    by Ralf Kiesslich, Hanan Adib-Tezer, Daniel Teubner, Thomas Frieling, Christiane Bayerl, Nina K. Wenda, Jan Gosepath


  • Open Access

    Fluorescein- and EGFR-Antibody Conjugated Silica Nanoparticles for Enhancement of Real-time Tumor Border Definition Using Confocal Laser Endomicroscopy in Squamous Cell Carcinoma of the Head and Neck

    by Anna Watermann, Rita Gieringer, Anna-Maria Bauer, Sven Kurch, Ralf Kiesslich, Wolfgang Tremel, Jan Gosepath, Juergen Brieger

    Intraoperative definition of tumor free resection margins in head and neck cancer is challenging. In the current proof-of-principle study we evaluated a novel silica nanoparticle-based agent for its potential use as contrast enhancer. We synthesized silica nanoparticles with an average size of 45 nm and modified these particles with the fluorescence stain fluorescein isocyanate (FITC) for particle detection and with epidermal growth factor receptor (EGFR)-targeting antibodies for enhanced tumor specificity. The nanoparticles exhibited good biocompatibility and could be detected in vitro and in vivo by confocal laser scanning microscopy. Additionally, we show in an ex vivo setting that these modified nanoparticles specifically bind to tumor samples and could be detected using a handheld confocal fluorescence endomicroscope. From a clinical point of view, we believe that this method could be used for tumor border contrast enhancement and for better intraoperative definition of R-0 tumor resection.